Literature DB >> 12761129

Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium.

Bruce A Vallance1, Wanyin Deng, Kevan Jacobson, B Brett Finlay.   

Abstract

Many studies have shown that genetic susceptibility plays a key role in determining whether bacterial pathogens successfully infect and cause disease in potential hosts. Surprisingly, whether host genetics influence the pathogenesis of attaching and effacing (A/E) bacteria such as enteropathogenic and enterohemorrhagic Escherichia coli has not been examined. To address this issue, we infected various mouse strains with Citrobacter rodentium, a member of the A/E pathogen family. Of the strains tested, the lipopolysaccharide (LPS) nonresponder C3H/HeJ mouse strain experienced more rapid and extensive bacterial colonization than did other strains. Moreover, the high bacterial load in these mice was associated with accelerated crypt hyperplasia, mucosal ulceration, and bleeding, together with very high mortality rates. Interestingly, the basis for the increased susceptibility was not due to LPS hyporesponsiveness, as the genetically related but LPS-responsive C3H/HeOuJ and C3H/HeN mouse strains were also susceptible to infection. Analysis of the intestinal pathology in these susceptible strains revealed significant crypt epithelial cell apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end label staining) as well as bacterial translocation to the mesenteric lymph nodes. Further studies with infection of SCID (T- and B-lymphocyte-deficient) C3H/HeJ mice demonstrated that loss of lymphocytes had no effect on bacterial numbers but did reduce crypt cell apoptosis and delayed mortality. These studies thus identify the adaptive immune system, crypt cell apoptosis, and bacterial translocation but not LPS responsiveness as contributing to the tissue pathology and mortality seen during C. rodentium infection of highly susceptible mouse strains. Determining the basis for these strains' susceptibility to intestinal colonization by an A/E pathogen will be the focus of future studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761129      PMCID: PMC155702          DOI: 10.1128/IAI.71.6.3443-3453.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Tolerance and immunity in the intestinal immune system.

Authors:  C Nagler-Anderson
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

2.  On the particularity of pathogens.

Authors:  B R Bloom
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice.

Authors:  R J North; R LaCourse; L Ryan; P Gros
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Heritable susceptibility for colitis in mice induced by IL-10 deficiency.

Authors:  I J Bristol; M A Farmer; Y Cong; X X Zheng; T B Strom; C O Elson; J P Sundberg; E H Leiter
Journal:  Inflamm Bowel Dis       Date:  2000-11       Impact factor: 5.325

Review 5.  Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport.

Authors:  S Gruenheid; P Gros
Journal:  Curr Opin Microbiol       Date:  2000-02       Impact factor: 7.934

Review 6.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Role of EspB in experimental human enteropathogenic Escherichia coli infection.

Authors:  C O Tacket; M B Sztein; G Losonsky; A Abe; B B Finlay; B P McNamara; G T Fantry; S P James; J P Nataro; M M Levine; M S Donnenberg
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 8.  The C3H/HeJBir mouse model: a high susceptibility phenotype for colitis.

Authors:  C O Elson; Y Cong; J Sundberg
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

Review 9.  Gut feelings: enteropathogenic E. coli (EPEC) interactions with the host.

Authors:  D L Goosney; S Gruenheid; B B Finlay
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

10.  Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB.

Authors:  G Frankel; A D Phillips; M Novakova; H Field; D C Candy; D B Schauer; G Douce; G Dougan
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

View more
  95 in total

1.  Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Anisha Chinthalapally; Pomila Singh; Shanjana Awasthi; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

3.  Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.

Authors:  Chien-Chang Chen; Steve Louie; Beth McCormick; W Allan Walker; Hai Ning Shi
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Host immune status influences the development of attaching and effacing lesions in weaned pigs.

Authors:  Francis Girard; Isabelle P Oswald; Ionélia Taranu; Pierre Hélie; Greg D Appleyard; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.

Authors:  Masaru Yoshida; Kanna Kobayashi; Timothy T Kuo; Lynn Bry; Jonathan N Glickman; Steven M Claypool; Arthur Kaser; Takashi Nagaishi; Darren E Higgins; Emiko Mizoguchi; Yoshio Wakatsuki; Derry C Roopenian; Atsushi Mizoguchi; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

6.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo.

Authors:  Benoît Foligné; Stéphanie-Marie Deutsch; Jérôme Breton; Fabien J Cousin; Joëlle Dewulf; Michel Samson; Bruno Pot; Gwénaël Jan
Journal:  Appl Environ Microbiol       Date:  2010-10-22       Impact factor: 4.792

8.  Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of Citrobacter rodentium infection.

Authors:  Fuyuan Wang; Jingjing Meng; Li Zhang; Sabita Roy
Journal:  Gut Microbes       Date:  2019-08-05

9.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

Review 10.  T helper 17 cells: discovery, function, and physiological trigger.

Authors:  Miriam Beer Torchinsky; J Magarian Blander
Journal:  Cell Mol Life Sci       Date:  2010-01-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.